Agilent Announces Collaboration With Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
January 31, 2024
January 31, 2024
SANTA CLARA, California, Jan. 31 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release on Jan. 30, 2024:
Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent's expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte's hematology and oncology . . .
Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent's expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte's hematology and oncology . . .